US Broker Ratings

MeiraGTx Holdings plc (MGTX) Stock Analysis: Unpacking a Promising 188% Upside in Biotech Innovation

Investors with a keen eye on the biotechnology sector should take a closer look at MeiraGTx Holdings plc (NASDAQ: MGTX). Known for its cutting-edge work in..

Cel-Sci Corporation (CVM) Stock Analysis: Exploring the Potential of a Biotech Challenger with a Unique Immunotherapy Approach

Cel-Sci Corporation (NASDAQ: CVM), a clinical-stage biotechnology firm, is carving a niche in the healthcare sector with its innovative approach to cancer treatment. Headquartered in Vienna,..

Rapport Therapeutics, Inc. (RAPP) Stock Analysis: A 34% Upside Potential in the Biotech Sector

Investors with an eye on the burgeoning biotechnology sector may find Rapport Therapeutics, Inc. (NASDAQ: RAPP) a compelling opportunity, especially with a potential upside of 34.23%..

Xencor, Inc. (XNCR) Stock Analysis: Exploring a 132% Potential Upside in Biotech

Xencor, Inc. (NASDAQ: XNCR) has captured investor attention with its promising pipeline of engineered antibodies targeting cancer and autoimmune diseases. As a clinical-stage biopharmaceutical company, Xencor’s..

Septerna, Inc. (SEPN) Stock Analysis: Unpacking a Potential 84% Upside in the Healthcare Biotech Arena

Septerna, Inc. (NASDAQ: SEPN) is capturing investor attention with its promising position in the biotechnology sector, focusing on breakthrough therapies for complex and underserved medical conditions...

Organogenesis Holdings Inc. (ORGO) Stock Report: Exploring a Potential 216% Upside

Organogenesis Holdings Inc. (NASDAQ: ORGO) is catching the eye of investors with a compelling potential upside of 216.21%, according to recent analyst ratings. This regenerative medicine..

Emergent BioSolutions Inc. (EBS): Investor Outlook with a Promising 31.43% Potential Upside

Emergent BioSolutions Inc. (NASDAQ: EBS), a key player in the healthcare sector, is garnering attention with an enticing potential upside of 31.43%. Investors are eyeing this..

Autolus Therapeutics plc (AUTL): Analyst Ratings Illuminate 438.99% Potential Upside in Biotech Stock

Autolus Therapeutics plc (NASDAQ: AUTL), a UK-based clinical-stage biopharmaceutical company, has captured the attention of investors with its promising pipeline of T cell therapies targeting cancer..

STAAR Surgical (STAA) Stock Analysis: Navigating the Potential in Visionary Healthcare

STAAR Surgical Company (NASDAQ: STAA), a significant player in the Medical Instruments & Supplies industry, has been making waves with its innovative approaches to vision correction...

Akebia Therapeutics, Inc. (AKBA) Investor Outlook: A Biotech with Significant Upside Potential

Akebia Therapeutics, Inc. (NASDAQ: AKBA) presents an intriguing opportunity for investors in the healthcare sector, particularly within the specialty and generic drug manufacturing industry. With a..

AngioDynamics, Inc. (ANGO) Investor Outlook: Analyzing a 59.72% Potential Upside

AngioDynamics, Inc. (NASDAQ: ANGO), a prominent player in the healthcare sector, stands out for its innovative contributions to medical technology. Headquartered in Latham, New York, AngioDynamics..

Butterfly Network, Inc. (BFLY) Stock Analysis: Exploring a 34% Potential Upside

Butterfly Network, Inc. (NYSE: BFLY), a prominent player in the healthcare sector, particularly in the medical devices industry, has been capturing the attention of investors with..

Celcuity Inc. (CELC) Stock Analysis: Biotechnology Innovator with a 20.5% Potential Upside

Celcuity Inc. (NASDAQ: CELC) stands out in the competitive biotechnology sector with its promising pipeline and strategic partnerships. Despite a recent minor dip of 0.06% in..

AxoGen, Inc. (AXGN) Stock Analysis: 17% Upside Potential Amid Robust Revenue Growth

AxoGen, Inc. (NASDAQ: AXGN), a key player in the healthcare sector specializing in medical devices for peripheral nerve regeneration, is capturing the attention of investors due..

Humacyte, Inc. (HUMA) Stock Analysis: Exploring a Potential 369% Upside in the Biotech Sector

For investors with a keen eye on the healthcare sector, Humacyte, Inc. (NASDAQ: HUMA) presents an intriguing opportunity. As a biotechnology company specializing in the development..

LifeMD, Inc. (LFMD) Stock Analysis: A Telehealth Contender with a Promising 119.93% Upside

LifeMD, Inc. (LFMD) stands at a pivotal point in the healthcare industry as a direct-to-patient telehealth pioneer, serving the U.S. market with a spectrum of medical..

AtaiBeckley Inc. (ATAI) Stock Analysis: Unveiling a Potential 249% Upside in the Biotech Sector

AtaiBeckley Inc. (ATAI), a clinical-stage biopharmaceutical company, stands at the forefront of mental health treatment innovation, boasting a market capitalization of $1.47 billion. Focused on developing..

AMN Healthcare Services Inc (AMN) Stock Analysis: Navigating a Challenging Landscape with Potential Opportunities

AMN Healthcare Services Inc (NYSE: AMN), a prominent player in the healthcare sector, is capturing attention with its comprehensive suite of workforce solutions tailored for the..

Simulations Plus, Inc. (SLP): Investor Outlook with a 47% Potential Upside

Simulations Plus, Inc. (NASDAQ: SLP) is a key player in the healthcare sector, specifically within the health information services industry. Headquartered in Research Triangle Park, North..

Sonida Senior Living, Inc. (SNDA) Stock Analysis: Navigating Growth Potential Amidst Financial Challenges

Sonida Senior Living, Inc. (SNDA), a notable player in the healthcare sector, specifically within the medical care facilities industry, is garnering attention for its strategic positioning..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds